Drug Type Small molecule drug |
Synonyms Calcium citrate tetrahydrate, 凯替, 司特立 |
Target- |
Action- |
Mechanism Calcium supplements |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization- |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date- |
Regulation- |
Molecular FormulaC12H24Ca3O18 |
InChIKeyZIBBYVVTDADECF-UHFFFAOYSA-N |
CAS Registry5785-44-4 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Calcium deficiency | China | - |
Phase 1/2 | 92 | Vitamin D (Vitamin D-Calcium) | zfkkpxvqey(ngtmbgzsfo) = iytlzhjjey whvrghyigs (hceuyxrhee, 170) View more | - | 30 Jul 2019 | ||
Vitamin D (Vitamin D Only) | zfkkpxvqey(ngtmbgzsfo) = vchrwizonx whvrghyigs (hceuyxrhee, 183) View more | ||||||
Phase 2/3 | - | 2,058 | - | - | 01 Mar 2019 | ||
Not Applicable | 36 | Vitamin D+Calcium Citrate | jroxapvzvt(toxlvudkol) = tdhnikaijn zlxohzwzbh (kbjgcphnar, 4.56) View more | - | 11 Sep 2018 | ||
Phase 2/3 | 2,813 | placebo (Full Factorial Placebo) | cpemyodinv = naymexutkg vaaitqrwqt (tgfakfdpuf, cgcciccwyd - fefddqlelf) View more | - | 20 Oct 2015 | ||
(Full Factorial Calcium) | cpemyodinv = zoyhflxjbm vaaitqrwqt (tgfakfdpuf, ooiedainho - kacbiusxpj) View more | ||||||
Not Applicable | - | 26 | Calcium group | fqiljzficb(mzjmcxmnci) = hgvbtoucdv dpyvobwzax (xzhcxvvcua, 8.3 - 32.8) View more | - | 01 Jan 2014 | |
(Placebo group) | fqiljzficb(mzjmcxmnci) = aiicuuqqii dpyvobwzax (xzhcxvvcua, 13.0 - 36.6) View more | ||||||
Not Applicable | - | Calcium + Vitamin-D + Estrogen therapy | talsdzqjvx(ogdvmexndp): Hazard Ratio = 1.5 (95% CI, 0.96 - 2.33), P-Value = 0.018 | - | 15 Apr 2008 | ||
Calcium + Vitamin-D + Placebo |